Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05498272
Title Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations (NePtune)
Acronym NePtune
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Rana McKay, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.